Letters/Comments
AHA letters and comments provide insight to legislators and policymakers about laws and regulations important to the healthcare field.
AHA comments on the CMS’ hospital outpatient prospective payment system and ambulatory surgical center payment system proposed rule for calendar year CY 2027.
AHA comments on two aspects of the Centers for Medicare & Medicaid Services’ (CMS) 2027 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems Rule.
AHA provides feedback on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act) discussion draft.
The AHA's principal recommendation is that CMS use its authority to require drug manufacturers to make the Maximum Fair Price (MFP) available through a prospective, point-of-sale mechanism and eliminate any option that would permit manufacturers to satisfy their obligations through retrospective…
The American Hospital Association input on the FDA report on the risks and benefits to health and safety that are associated with non-device software as required under Section 3060 of the 21st Century Cures Act.
The American Hospital Association provides comments on the Consumer Product Safety Commission’s agenda and priorities for fiscal years 2027 and 2028.
the American Hospital Association provides comments on the Rural Health Transformation Program.
American Hospital Association (AHA) comments on the Centers for Medicare & Medicaid Services (CMS) interim final rule on Medicaid community engagement requirements.
This letter provides comment on the American Hospital Association's support of the National Nursing Workforce Center Act of 2025 (S. 1482).
The American Hospital Association comments on the CMS proposed rule regarding Medicaid managed care state-directed payments and Medicaid fee-for-service targeted practitioner payments.